Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets

Universal access to antiretroviral therapy (ART) in low- and middle-income countries faces numerous challenges: increasing numbers of people needing ART, new guidelines recommending more expensive antiretroviral (ARV) medicines, limited financing, and few fixed-dose combination (FDC) products. Globa...

Full description

Saved in:
Bibliographic Details
Main Authors: Waning, Brenda (Author) , Kyle, Margaret K. (Author) , Bärnighausen, Till (Author) , Moon, Suerie (Author)
Format: Article (Journal)
Language:English
Published: 25 May 2010
In: Globalization and health
Year: 2010, Volume: 6, Pages: 9
ISSN:1744-8603
DOI:10.1186/1744-8603-6-9
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/1744-8603-6-9
Verlag, kostenfrei, Volltext: https://doi.org/10.1186/1744-8603-6-9
Get full text
Author Notes:Brenda Waning, Margaret Kyle, Ellen Diedrichsen, Lyne Soucy, Jenny Hochstadt, Till Bärnighausen, Suerie Moon
Description
Summary:Universal access to antiretroviral therapy (ART) in low- and middle-income countries faces numerous challenges: increasing numbers of people needing ART, new guidelines recommending more expensive antiretroviral (ARV) medicines, limited financing, and few fixed-dose combination (FDC) products. Global initiatives aim to promote efficient global ARV markets, yet little is known about market dynamics and the impact of global policy interventions.
Item Description:Gesehen am 18.08.2017
Physical Description:Online Resource
ISSN:1744-8603
DOI:10.1186/1744-8603-6-9